We demonstrate that ST6Gal-I expression in ovarian tumor cells confers resistance to cisplatin-mediated cell death and that cell lines selected for resistance to cisplatin strongly express ST6Gal-I. This evidence concerns the gene ST6GAL1 and ovarian neoplasm.